GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines that prevent and fight human immunodeficiency virus (HIV). The companys vaccines are being evaluated to determine their potential to prevent HIV infection and to serve as a treatment for individuals already infected with HIV. The firm is also developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with a wide range of federal sources and academic institutions in the US and verseas
